Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Verneris

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2013
Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVLMichael R Verneris
Current Hematologic Malignancy Reports|May 7, 2010
Novel approaches to prevent leukemia relapse following allogeneic hematopoietic cell transplantationMichael R Verneris, Michael J Burke
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Recent developments in cell-based immune therapy for neuroblastomaMichael R Verneris, John E Wagner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Natural killer cell consolidation for acute myelogenous leukemia: a cell therapy ready for prime time?Michael R Verneris, Stephan A Grupp
Blood|January 30, 2010
UCB and atmospheric noiseMichael R Verneris, John E Wagner
Blood|October 25, 2014
KIR B or not to be?...that is the question for ALLMichael R Verneris, Jeffrey S Miller
JCI Insight|March 22, 2021
Therapeutic manipulation of innate lymphoid cellsLaura M Cobb, Michael R Verneris
Blood|May 22, 2010
The TREC to less CMV after UCBTJill C Beck, Michael R Verneris
British Journal of Haematology|October 3, 2009
The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cellsMichael R Verneris, Jeffrey S Miller
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Is It Better to Be Rich or Relaxed? Sociobiology Meets Bone Marrow TransplantLucie M Turcotte, Michael R Verneris
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Hematology. American Society of Hematology. Education Program|December 10, 2013
Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVLMichael R Verneris
Current Hematologic Malignancy Reports|May 7, 2010
Novel approaches to prevent leukemia relapse following allogeneic hematopoietic cell transplantationMichael R Verneris, Michael J Burke
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Recent developments in cell-based immune therapy for neuroblastomaMichael R Verneris, John E Wagner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Natural killer cell consolidation for acute myelogenous leukemia: a cell therapy ready for prime time?Michael R Verneris, Stephan A Grupp
Blood|January 30, 2010
UCB and atmospheric noiseMichael R Verneris, John E Wagner
Blood|October 25, 2014
KIR B or not to be?...that is the question for ALLMichael R Verneris, Jeffrey S Miller
JCI Insight|March 22, 2021
Therapeutic manipulation of innate lymphoid cellsLaura M Cobb, Michael R Verneris
Blood|May 22, 2010
The TREC to less CMV after UCBTJill C Beck, Michael R Verneris
British Journal of Haematology|October 3, 2009
The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cellsMichael R Verneris, Jeffrey S Miller
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Is It Better to Be Rich or Relaxed? Sociobiology Meets Bone Marrow TransplantLucie M Turcotte, Michael R Verneris
Pageof 21